|
ABCD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.761400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.075800E-01 |
| Normal-vs-Stage2 |
7.343600E-01 |
| Normal-vs-Stage3 |
3.561600E-01 |
| Normal-vs-Stage4 |
7.498100E-02 |
| Stage1-vs-Stage2 |
7.634200E-01 |
| Stage1-vs-Stage3 |
3.405800E-01 |
| Stage1-vs-Stage4 |
4.994400E-02 |
| Stage2-vs-Stage3 |
7.194200E-01 |
| Stage2-vs-Stage4 |
3.069400E-01 |
| Stage3-vs-Stage4 |
3.583400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.143000E-01 |
| Normal-vs-AfricanAmerican |
3.359800E-01 |
| Normal-vs-Asian |
2.511000E-01 |
| Caucasian-vs-AfricanAmerican |
2.070000E-01 |
| Caucasian-vs-Asian |
4.721400E-01 |
| AfricanAmerican-vs-Asian |
1.271820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.936800E-01 |
| Normal-vs-Female |
7.739000E-01 |
| Male-vs-Female |
3.169200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.226000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.925800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.246200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.660040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.114600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.129200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.814800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.796200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.262200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.002000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.036820E-01 |
| Classical-VS-Follicular |
4.578400E-02 |
| Classical-VS-Other |
3.776800E-01 |
| Classical-VS-Normal |
7.095800E-01 |
| Tall-VS-Follicular |
9.254800E-01 |
| Tall-VS-Other |
7.671800E-01 |
| Tall-VS-Normal |
2.668000E-01 |
| Follicular-VS-Other |
8.550400E-01 |
| Follicular-VS-Normal |
1.966420E-01 |
| Other-VS-Normal |
3.549200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.066400E-01 |
| Normal-vs-N1 |
3.066100E-02 |
| N0-vs-N1 |
1.644630E-01 |
|
|
